Technetium 99m-hexakis-2-methoxy-2-methylpropyl-isonitrile (Tc-MIBI) is a promising new myocardial perfusion imaging agent producing excellent rest images. Imaging, however, will need to be performed with exercise or dipyridamole to detect ischemia and to differentiate salvaged but still ischemic myocardium from scar. Accordingly, 12 dogs were given mild-to-moderate left circumflex coronary stenoses (group 2), and 10 dogs were given severe stenoses (group 3). In five control dogs (group 1), there was no stenosis. After an intravenous infusion of dipyridamole (0.08 mg/kg/min for 4 minutes), Tc-MIBI was injected into the right atrium. Over the next 4-hour study period, myocardial Tc-MIBI activities were continuously monitored in both the left anterior descending (LAD) (normal) and left circumflex (LCx) (ischemic) coronary artery (ischemic) zones using miniature cadmium telluride radiation detectors and serial gamma camera images were acquired when necessary. Tc-MIBI was rapidly taken up by nonischemic, mild-to-moderate, and severe ischemic myocardium. The initial myocardial uptake of Tc-MIBI was linearly related (r=0.97) to regional myocardial blood flow at rates up to 2.0 ml/min/g. After the initial uptake, the mean 4-hour fractional myocardial clearance was similar between the control (0.09±0.03 [±SEMI) and group 2 (0.07±0.03) and group 3 (0.09±0.03) ischemic zones. Tc-MIBI blood clearance was rapid and biexponential with an initial fast clearance phase followed by a slow clearance phase. Both initial and final gamma camera images were qualitatively and quantitatively excellent in all three groups with favorable heart-to-lung ratios (initial, 2.72±0.15; final, 3.05 z0.16; n=27). Moreover, images from ischemic groups 2 and 3 demonstrated initial defects with no visible redistribution over 4 hours. Thus, after dipyridamole, Tc-MIBI 1) demonstrates minimal and similar clearance from normal and flow-restricted myocardium, 2) clears rapidly and biexponentially from the blood pool, and 3) produces gamma camera images that remain stable over a several-hour period because of the minimal clearance and insignificant redistribution. (Circulation 1990;81:628-636) A new class of technetium 99m isonitrile com-plexes has been introduced for myocardial perfusion imaging.1 The most promising member of this class is technetium 99m-hexakis-2-methoxy-2-methylpropyl isonitrile (Tc-MIBI), which has favorable characteristics for myocardial scintigraphy at rest.2 Good myocardial uptake of this agent has been found in a number of animal species.2-4 Additionally, Tc-MIBI has been safely administered to patients, and good initial uptake has been demonstrated.5
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A new class of technetium 99m isonitrile complexes has been introduced for myocardial perfusion imaging. 1 The most promising member of this class is technetium 99m-hexakis-2-methoxy-2-methylpropyl isonitrile (Tc-MIBI), which has favorable characteristics for myocardial scintigraphy at rest.2 Good myocardial uptake of this agent has been found in a number of animal species. [2] [3] [4] Additionally, Tc-MIBI has been safely administered to patients, and good initial uptake has been demonstrated. 5 We have described Tc-MIBI kinetics at rest in both normal and ischemic myocardium.2 Diagnostic imaging, however, will probably have to be performed with exercise or dipyridamole (DP) to detect coronary artery stenoses not severe enough to produce resting ischemia. Accordingly, the objectives of the present study were, after intravenous DP, to 1) define the myocardial kinetics of Tc-MIBI in normal, mild-moderate, and severe flow-reduced zones, 2) define and model Tc-MIBI blood kinetics, 3) determine if there is significant redistribution, and 4) define the relation between myocardial flow and Tc-MIBI uptake.
Methods
Twenty-seven adult mongrel dogs (mean weight, 21.4+±0.56 kg; range, 14.6-25.9 kg) were anesthetized with sodium pentobarbital (26 mg/kg i.v.). Additional anesthesia was given throughout the experiment as necessary. The dogs were intubated and placed on a respirator (Harvard Apparatus, South Natick, Massachusetts) with 5 cm of end-expiratory pressure and 95% oxygen. Twenty-centimeter vinyl EXPERIMENTAL PROTOCOL catheters were inserted into femoral and carotid arteries to monitor arterial pressure, to provide a site for microsphere reference blood withdrawal, and to obtain specimens of blood for the determination of arterial pH, Pco2, and Po2. Appropriate adjustments were made to maintain these parameters within a normal physiologic range (pH=7.35-7.45 and Pc02=30-40 mm Hg). Arterial Po2 was maintained above 150 mmHg throughout the experiment. A 20-cm vinyl catheter was also inserted into a femoral vein as a site for the infusion of DP and for the administration of fluids as required. The heart was then exposed by a left thoracotomy, suspended in a pericardial cradle, and 10-cm vinyl catheters were inserted into the right and left atria. A Swan-Ganz thermodilution catheter was inserted into the jugular vein and passed through the right side of the heart until its tip rested in the pulmonary artery. The left circumflex (LCx) coronary artery was then dissected free, and an electromagnetic flow probe was placed around the artery. A snare occluder was loosely positioned distal to the electromagnetic flow probe. A stiff 22-gauge, 8-in. catheter (Deseret Medical, Inc., Sandy, Utah) was inserted retrograde into a small branch of the LCx coronary artery for monitoring pressure distal to the snare occluder. A miniature cadmium telluride radiation detector probe attached to a modified arterial clamp was positioned against the left ventricular posterior wall epicardium by inserting the free arm of the clamp through the left ventricular apex. A similar probe was positioned against the left ventricular anterior wall epicardium. These detectors allowed continuous monitoring of regional myocardial Tc-99m activity in two regions of the heart. The physical characteristics of these detectors have been previously reported.6 The detectors were connected by preamplifiers to a multichannel analyzer (Series 30, Canberra Industries, Meriden, Connecticut) operating in multichannel scaling mode. The analyzer provided a continuous display of 99mTc activity in both regions. The radiation count data was continuously recorded on paper tape and stored on magnetic tape. Preparation of Technetium 99m-Hexakis-2-Methoxy-2-Methylpropyl-Isonitrile Stock solutions of isonitrile salt (Cu[MIBI]4BF4) and formamidine sulfinic acid were prepared at concentrations of 4.0 mg/ml and 0.4 mg/ml, respectively. The solutions were then frozen in 1.0-ml aliquots. On the day of each experiment, a 1.0-ml aliquot of each solution was thawed and 0.5 ml of each solution was added to a nitrogen-purged vial. Without delay, 30 mCi of 99mTcO4 was added to the solution in the nitrogen-purged vial, and it was then heated in a water bath at 1000 C for 10 minutes. After cooling, 5 mCi of the compound was withdrawn into a lead-shielded syringe. To evaluate the purity of the radiopharmaceutical, Sep-Pak analyses and thinlayer chromatography were performed. Using Sep-Pak analysis, over 97% of the Tc-MIBI compound remained bound to the cartridge. The compound chromatographed with an Rf equal to 0.54. Figure 1 describes the experimental protocol. Baseline steady-state hemodynamic measurements were recorded in all 27 dogs. In 22 dogs, varying degrees of LCx coronary artery stenosis were created by the partial occlusion of the artery with the snare occluder. The snare was adjusted until there was either partial or complete elimination of the hyperemic response to a brief LCx coronary artery total occlusion as measured by the electromagnetic flowmeter. In five control dogs, the LCx coronary artery was not occluded. A microsphere blood flow determination was then made by injecting 2-3 million 15-17 gm microspheres into the left atrium. The microspheres used were either Sn-113, Ru-103, Nb-95, or Sc-46. Microsphere reference blood collection was begun 10 seconds before each microsphere injection and continued for 2 minutes after the injection. The microsphere technique has been used extensively in our laboratory and has been previously described.7 A thermodilution cardiac output determination was also made at this time. Thirty minutes later, in a manner similar to that used clinically with thallium, an intravenous infusion of DP (0.08 mg/kg/min) was begun and continued over 4.0 minutes. Previous experiments from our laboratory have shown this dose to be effective in dogs, with higher doses producing pronounced hypotension. Two minutes after discontinuing the DP infusion, 5.0 mCi of Tc-MIBI was injected into the right atrium. Simultaneously, a second set of microspheres was injected into the left atrium, and a second cardiac output determination was made.
Experimental Protocol
Immediately after the Tc-MIBI injection, the radiation detectors continuously measured myocardial Tc-99m activity in both the normal and ischemic regions of the heart over the next 4 hours. Serial gamma camera images were also acquired over this period. To quantify blood Tc-99m activity over time, serial 1.0-ml arterial blood samples were collected at 2, 4, 6, 8, 10, 20, 30, 60, 90, 120, 180, and 240 minutes after injection. At the end of the 4-hour period, a third set of microspheres was injected into the left atrium, and a third cardiac output determination was made. After collecting microsphere reference blood samples, the dogs were killed.
After killing, the hearts were removed, and the left ventricles were separated and divided into normal and ischemic regions. Each myocardial region was then cut into 24 samples, weighing 0.8-1.2 grams per sample. Within 5-6 hours of collection, the serial blood samples and the myocardial tissue samples were counted for Tc-99m activity in a gamma well counter (model 1282, LKB Instruments, Gaithersburg, Maryland) with a window setting of 120-180 keV for 5 minutes each. The next day, the microsphere reference blood samples and the same myocardial tissue samples were again counted in the gamma well counter for 5 minutes each with appropriate window settings. The Sn-113 was counted within a 350-435 keV window, the Ru-103 within a 450-550 keV window, the Nb-95 within a 660-800 keV window, and the Sc-46 within a 810-1,200 keV window. A computer (Pro 350, Digital Equipment Corp., Marlboro, Massachusetts) was used to correct for spillover of activity from one window into another and to calculate regional myocardial blood flow. Blood flow was expressed as ml/min/g of tissue and as a ratio of the LCx (ischemic) zone divided by the left anterior descending (LAD) (normal) zone.
When the microsphere flow data had been analyzed, the 22 dogs that were given LCx coronary artery stenoses were divided into two groups based on the severity of the stenosis as determined by the pre-DP microsphere flow ratio. Twelve of 22 dogs had a mild-to-moderate stenosis with an ischemicto-normal zone flow ratio greater than or equal to 0.60 (group 2). Ten of 22 dogs had a severe stenosis with an ischemic-to-normal flow ratio less than 0.60 (group 3). The five control dogs were defined as group 1.
Tc-MIBI Distribution Versus Blood Flow
To determine the relation between initial Tc-MIBI distribution and regional myocardial blood flow after DP, the LCx coronary arteries of four additional dogs were completely occluded. After an intravenous infusion of DP, 5 mCi of Tc-MIBI was injected into the right atrium, and microspheres were simultaneously injected into the left atrium. Immediately after the collection of microsphere reference blood samples, the dogs were killed. After killing, the hearts were removed and divided into 96 segments and counted for Tc-MIBI and microsphere activity in a gamma scintillation counter as previously described. This yielded a total of 384 (96 segmentsx4 dogs) segments for analysis.
Gamma Camera Imaging Technique
Images of the heart were obtained with a conventional gamma scintillation camera (Mobile Radioisotope Camera, model 420, Ohio-Nuclear Inc., Solon, Ohio) interfaced with a nuclear imaging computer system (DPS 2800, ADAC Laboratories, Milpitas, California). A general all-purpose parallel-hole collimator was used with a 20% energy window encompassing the 140 keV Tc-99m photopeak. Imaging was performed in the left lateral projection with the chest open. A lead shield was placed over the abdomen of each dog to partially eliminate splanchnic activity. The images were collected in a 128 x 128 x 16 matrix at the time of Tc-MIBI administration and at 30, 60, 120, 180, and 240 minutes later. Image quality was assessed both qualitatively and quantitatively using targetto-background (heart-to-lung) pixel-count ratios.
Statistics and Analysis Methods
All results were expressed as mean± 1 SEM. The significance of a difference in means between groups was assessed using a multivariate general linear hypothesis procedure with a one-way analysis of variance design. Within-group comparisons were made using a paired t test. The serial blood data from each dog was analyzed using a Quasi-Newton nonlinear-regression technique.
Results

Hemodynamics
There were no differences between the control group versus the mild-to-moderate ischemia or severe ischemia groups for any of the hemodynamic variables summarized in Table 1 . Both mean arterial and coronary pressure decreased significantly after DP in all three groups. There were no significant changes in heart rate, left atrial pressure, or cardiac output after DP in any of the groups.
Myocardial Blood Flow
The microsphere-determined regional myocardial blood flow ratios for all three groups of dogs are shown in Table 2 and Figure 2 . In the five control dogs (group 1), the mean ratio of the LCx coronary artery (ischemic zone) blood flow to LAD coronary artery (normal zone) blood flow was 0.85±0.07 pre-DP, 0.91±0.13 post-DP, and 0.87±0.08 at the end of the experiment (p=NS). In the 12 mild-to-moderate stenosis dogs (group 2), the mean-ischemicto-normal-zone-blood-flow ratio was 0.86±0.04 pre-DP, 0.58+0.05 post-DP (p=0.00), and 0.68+0.06 at the end of the experiment. In the 10 severe stenosis dogs (group 3), the mean-ischemic-to-normalzone-blood-flow ratio was 0.34±+ 0.05 pre-DP, 0.22±0.05 post-DP (p=NS), and 0.30±0.06 at the end of the experiment. Figure 3 demonstrates the data from the four dogs killed immediately after DP infusion followed by simultaneous microsphere and Tc-MIBI administration. There was a linear relation between the initial myocardial distribution of Tc-MIBI and coronary blood flow at rates up to 2.0 ml/min/g (r=0.97). At very low flow rates (<0.3 ml/min/g), however, Tc-MIBI tends to overestimate flow, and at high flow rates (>2.0 ml/min/g), Tc-MIBI underestimates myocardial blood flow. Table 3 contains the decay-corrected 4-hour myocardial and blood clearance data for the individual dogs. Myocardial clearance was calculated from the background and decay-corrected radiation probe data and was defined as final counts subtracted from initial counts, then divided by initial counts. In Figure 4 , the individual myocardial activities recorded by the multichannel analyzer for each group of dogs were decay-corrected, normalized, and then averaged minute by minute. As shown in this figure, the mean 4-hour myocardial clearances for the three groups of dogs were minimal and, therefore, could not be modeled. Figure 5 demonstrates the mean 4-hour fractional myocardial clearances for the three groups. Mean fractional clearance from the normal zone was 0.10±0.04 SE and 0.09±0.03 for group 1, 0.11±0.02 for group 2, and 0.14±0.03 for group 3. Mean fractional clearance from the ischemic zone was 0.07±0.03 for group 2 and 0.09±0.03 for group 3. There was no significant difference in 4-hour fractional myocardial clearance after DP among any of the three groups of dogs, or between the normal and ischemic zones within each group.
Initial Myocardial Distribution of Tc-MIBI With Flow
Myocardial and Blood Tc-MIBI Kinetics
Serial blood samples taken during each experiment were analyzed using a Quasi-Newton nonlinear-regression software module. The parameter values from this analysis are shown in Table 3 . Figure 6 demonstrates the "best-fit" curves resulting from the mathematical modeling of Tc-MIBI blood pool clearance in the three groups of dogs. Tc-MIBI blood pool clearance was determined to be biexponential and similar between the three groups. During the initial phase, Tc-MIBI blood pool clearance was extremely rapid with effective half-lives of 1.31, 1.56, and 1.65 minutes in groups 1, 2, and 3, respectively. After the first few minutes, Tc-MIBI blood pool clearance was slow with effective half-lives of 71.4, 62.5, and 90.9 minutes. Gamma Camera Images Gamma camera images from the three groups of dogs were qualitatively and quantitatively excellent initially and 4 hours later because of the minimal myocardial clearance and insignificant redistribution of the tracer. Initially, heart-to-lung pixel ratios were 2.5+0.26 in group 1, 2.7±0.19 in group 2, and 3.0±0.41 in the group 3 dogs. Four hours later, the heart-to-lung ratios were 2.8±0.09 in group 1, 3.1±0.19 in group 2, and 3.3+0.55 in group 3. There were no differences among the groups in heartto-lung ratios initially or at 4 hours. In all 3 groups, there was a trend toward improvement in heartto-lung ratio over time, although statistical significance was reached only in group 2. Mean heartto-lung ratios for all 27 dogs pooled together were 2.72±0.15 initially, and 3.05±0.16 at 4 hours. Figure 7 demonstrates the gamma camera images acquired initially, 1 hour, and 4 hours after Tc-MIBI administration from a control dog. As can be seen in the figure, myocardial images were of excellent qual- ity initially and 1 hour later. The initial heart-to-lung ratio in this dog was 2.82. Although there was prominent lung and splanchnic activity initially, at 1 hour, the lung activity was diminished, and at 4 hours, the heart-to-lung ratio was 2.88. The splanchnic activity was partially shielded during acquisition. All of the dogs in the control group had homogeneous Tc-MIBI distribution with no visible perfusion defects present. Figure 8 demonstrates the gamma camera images from a dog with mild-to-moderate ischemia in the LCx coronary artery (group 2). This particular dog had a resting-flow ratio of 0.64, which dropped to 0.50 with DP. There was an initial posterior wall perfusion defect, which persisted at 4 hours. Visual inspection showed no qualitative evidence of redistribution in any of the images from this group of dogs. Heart-to-lung ratios for this dog were 2.83 initially, and 3.23 4 hours later. Posterior wall defects were visible in nine out of the 10 studies in which images were acquired. Two studies from this group had no images due to gamma camera malfunction. Figure 9 demonstrates the gamma camera images from a dog with severe ischemia (group 3). In this dog, the flow ratio was 0.46 at rest, and it dropped to 0.22 with DP. As shown in this figure, there was a prominent left ventricular posterior wall defect present initially, which persisted 4 hours later. There was no redistribution visible in the images from these dogs. Heart-to-lung ratios for this dog were 2.95 initially and 3.03 4 hours later. All studies in this group had prominent posterior wall defects.
Discussion
Thallium 201 (Tl-201) has been widely used for the assessment of myocardial perfusion and the diagnosis of coronary artery disease. Unfortunately, the physical properties of Tl-201 are not ideal for gamma camera imaging, and myocardial image quality has sometimes suffered from external or self attenuation. Additionally, TI-201 is cyclotron produced and is, therefore, not readily available. Tc-99m is better suited for gamma camera imaging because of its 140 keV gamma photon. Previous attempts to link Tc-99m to various carriers, how-Pre-DP, predipyridamole infusion; Post-DP, postdipyridamole infusion; End, end of study; group 1, control; group 2, mildto-moderate ischemia; group Table 2. Y1 and Y2, early and late Y intercepts; Li and L2, early and late exponential decay constants. ever, have been limited by either poor myocardial uptake, toxicity, or high lung or liver uptake. 8, 9 Recently, a new class of Tc-99m isonitrile complex myocardial perfusion imaging agents has been introduced.' Tc-MIBI is the most promising member of this new class. Because diagnostic imaging will likely need to be performed with exercise or DP to detect coronary artery stenoses not severe enough to produce resting ischemia, the current study was undertaken to describe the kinetics of Tc-MIBI in normal and ischemic myocardium after intravenous DP.
Hemodynamic Response to Intravenous Dipyridamole
In the current study, there was a decrease in mean systemic arterial pressure, a decrease in coronary artery pressure distal to the stenosis, and no significant change in either heart rate, left atrial pressure, or cardiac output after intravenous DP infusion.
Previous studies in anesthetized open-chest dogs have shown similar results.10-13 Studies in intact conscious dogs have demonstrated no significant decrease in systemic arterial pressure with intravenous DP.14 In patients, minor but significant increases in cardiac output and heart rate and decreases in systemic arterial pressure have been demonstrated. 15',6 Microsphere-determined coronary artery blood flow in the normal zones showed a mean 115% increase after intravenous DP. This is consistent with previous studies10 in normal dogs that demonstrated a 35-400% increase in coronary artery blood flow with intravenous DP, depending on the dose. In this group, as in other studies from our laboratory,17'8 the ratio between the control LAD and control LCx zone flows remained near unity throughout the experiment. In the mild-to-moderate stenosis group (group 2), the mean-flow ratio at rest was near unity but decreased significantly with DP. This finding demonstrates the ability of DP to unmask flow disparities not apparent at rest, and is consistent with our previous studies. 17, 18 The severe stenosis group (group 3) demonstrated a significant reduction in the mean-flow ratio at rest. As in the previous study from our laboratory,'8 there was further reduction in the flow ratio with DP although it did not reach statistical significance in this study (p=0.059).
Initial Myocardial Distribution of Tc-MIBI With Flow
In a previous study from our laboratory using a canine model of a fixed coronary artery stenosis, we demonstrated a close correlation (r=0.92) between the initial distribution of Tc-MIBI and coronary blood flow at normal resting-flow rates.2 During the current study using intravenous DP, the initial distribution of Tc-MIBI was also shown to be The mean capillary permeabilitysurface area product (PScap, ml/min/g) for Tc-MIBI was 0.43 and was threefold lower than for thallium.
Myocardial and Blood Tc-MIBI Kinetics
The current study used miniature implantable radiation detectors to monitor Tc-MIBI myocardial kinetics. These detectors have been previously validated in our laboratory6 and allow a continuous assessment of myocardial Tc-MIBI activity from precise areas of the myocardium. Before their development, the myocardial kinetics of a radiopharmaceutical could be monitored only by serial myocardial punch or drill biopsies. Biopsy techniques provided information noncontinuously and inflicted severe trauma to the myocardium.
The current study demonstrated that the 4-hour fractional myocardial Tc-MIBI clearances post-DP from both normal zones in the control dogs (group 1) were minimal (LAD, 0.10 +0.04; LCx, 0.09+0.03) and consistent with our previous study with Tc-MIBI in a resting dog model (LAD, 0.11+0.06; LCx, 0.10±0.07).2 In both of these studies, there was a rapid time to peak myocardial Tc-99m activity occurring within the first minute after injection in normal flow zones. Our laboratory has also examined the myocardial kinetics of Tl-201 after intra-0-. a 50' l --w Initial 1 Hour venous DP infusion in both normal and flowreduced myocardium. 18 Compared with thallium clearance in normal myocardium post-DP (0.35±0.03), the 4-hour fractional myocardial Tc-MIBI clearance was slow. After DP, Tl-201 also demonstrated a rapid time to peak myocardial activity. The current study also demonstrated minimal and similar 4-hour fractional myocardial clearance post-DP from mild-to-moderate ischemia zones (group 2, 0.07±0.03) and severe ischemia zones (group 3, 0.09±0.03) as compared with a normal control zone in each group (0.11+0.02 and 0.14±0.03, respectively). As in the control dogs, the initial myocardial uptake of Tc-MIBI occurred rapidly within the first minute although the activity in the ischemic zone was reduced. These results are similar to our previous study with Tc-MIBI in a resting dog model of LCx stenosis.2 In dogs at rest, 4-hour fractional myocardial clearances from normal and ischemic zones were minimal and equivalent (0.15+0.05 SD vs. 0.15±0.07), and the initial myocardial uptake of Te-MIBI occurred rapidly.
The results of the current study differed, however, from our previous studies with thallium in which the 4-hour myocardial clearance rate decreased progressively distal to a stenosis of increasing severity and, thus, could differentiate between stenoses of graded hemodynamic severity. 18 The similar myocardial fractional clearances between the normal and ischemic zones also confirmed the visual absence of redistribution on gamma camera images during 4 hours. There was prominent lung activity initially, which was diminished at 1 hour. There was also considerable splanchnic activity, which was partially shielded during acquisition in these images. S, septum; P, posterior wall; A, apex.
Hours
Serial blood samples taken during 4 hours demonstrated biexponential Te-MIBI blood pool clearance with a fast initial component followed by a slow late component. In a multicenter phase 1 clinical trial of Tc-MIBI, Wackers et a15 also reported biexponential Te-MIBI blood clearance from 17 normal volunteers at rest and after exercise.
Gamma Camera Image Quality
In the current study, serial gamma camera images were of excellent quality and remained stable over the 4-hour study period because of the minimal Te-MIBI clearance and the visual absence of redistribution in all three groups of dogs. Although there was relatively high visceral uptake of Tc-MIBI initially, this activity had diminished by 1 hour. We have observed similarly high quality gamma camera images with Tc-MIBI in dogs at rest. 2 The results of the current study agree with the phase 1 clinical studies conducted by Wackers et al. 5 They concluded that Tc-MIBI images were of better quality than companion Tl-201 images and that the optimal timing for Tc-MIBJ imaging was 60 minutes after injection, when liver activity had cleared. These investigators also concluded that the timing of Te-MIBI initial imaging is not as critical as for TI-201, again because of minimal Tc-MIBI clearance and lack of redistribution. In another recent clinical study on 27 patients, Taillefer et a121 performed imaging with both TI-201 and Tc-MIBI after intravenous DP. Using a same-day injection protocol, these investigators found good correlation between Tl-201 and 
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Tc-MIBI on both a segmental and on a patientby-patient basis.
Clinical Implications
From a clinical standpoint, the minimal 4-hour fractional myocardial clearance in normal, mildto-moderate flow-reduced, and severe flow-reduced zones, and the lack of redistribution, would allow for the acquisition of initial myocardial images at a convenient time rather than immediately after the administration of the radiotracer. Compared with thallium imaging, however, the minimal Tc-MIBI redistribution with DP can make it difficult to assess myocardial viability with a single study. A second study after the stress study might be necessary to differentiate ischemia from scar. After intravenous DP infusion. Te-MIBI is rapidly taken up by nonischemic, mild-to-moderate, and severely ischemic myocardium. The initial distribution of Tc-MIBI is proportional to regional myocardial blood flow at rates up to 2.0 ml/min/g. After the initial uptake, myocardial Tc-MIBI clearance is minimal and similar between nonischemic and ischemic myocardium with different degrees of stenosis. Tc-MIBI blood pool clearance is rapid and biexponential with a fast early phase followed by a slow late phase. The good myocardial uptake, minimal clearance, and lack of redistribution produced stable gamma camera images in dogs for up to 4 hours after Tc-MIBI administration. Therefore, Tc-MIBI should be well suited for imaging with DP.
